317 related articles for article (PubMed ID: 18488412)
41. The upcoming field of theranostic nanomedicine: an overview.
Prabhu P; Patravale V
J Biomed Nanotechnol; 2012 Dec; 8(6):859-82. PubMed ID: 23029995
[TBL] [Abstract][Full Text] [Related]
42. Respiratory follow-up of patients with COVID-19 pneumonia.
George PM; Barratt SL; Condliffe R; Desai SR; Devaraj A; Forrest I; Gibbons MA; Hart N; Jenkins RG; McAuley DF; Patel BV; Thwaite E; Spencer LG
Thorax; 2020 Nov; 75(11):1009-1016. PubMed ID: 32839287
[TBL] [Abstract][Full Text] [Related]
43. Nanocarriers for respiratory diseases treatment: recent advances and current challenges.
Trapani A; Gioia SD; Castellani S; Carbone A; Cavallaro G; Trapani G; Conese M
Curr Top Med Chem; 2014; 14(9):1133-47. PubMed ID: 24678708
[TBL] [Abstract][Full Text] [Related]
44. Pulmonary drug delivery systems: recent developments and prospects.
Courrier HM; Butz N; Vandamme TF
Crit Rev Ther Drug Carrier Syst; 2002; 19(4-5):425-98. PubMed ID: 12661699
[TBL] [Abstract][Full Text] [Related]
45. Nanotechnology in Insulin Delivery for Management of Diabetes.
Bahman F; Greish K; Taurin S
Pharm Nanotechnol; 2019; 7(2):113-128. PubMed ID: 30907328
[TBL] [Abstract][Full Text] [Related]
46. Supramolecular nanodevices: from design validation to theranostic nanomedicine.
Cabral H; Nishiyama N; Kataoka K
Acc Chem Res; 2011 Oct; 44(10):999-1008. PubMed ID: 21755933
[TBL] [Abstract][Full Text] [Related]
47. Drugs and the respiratory system.
Bailey R
Nursing (Lond); 1979 Nov; (7):315-8. PubMed ID: 261253
[No Abstract] [Full Text] [Related]
48. Nanodelivery in airway diseases: challenges and therapeutic applications.
Roy I; Vij N
Nanomedicine; 2010 Apr; 6(2):237-44. PubMed ID: 19616124
[TBL] [Abstract][Full Text] [Related]
49. Cell-targeting and cell-penetrating peptides for delivery of therapeutic and imaging agents.
Juliano RL; Alam R; Dixit V; Kang HM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):324-35. PubMed ID: 20049800
[TBL] [Abstract][Full Text] [Related]
50. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides.
Batista P; Castro PM; Madureira AR; Sarmento B; Pintado M
Peptides; 2018 Mar; 101():112-123. PubMed ID: 29329977
[TBL] [Abstract][Full Text] [Related]
51. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier.
Dey M; Das M; Chowhan A; Giri TK
Int J Biol Macromol; 2019 Jun; 130():34-49. PubMed ID: 30779985
[TBL] [Abstract][Full Text] [Related]
52. Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.
Dawre S; Maru S
Life Sci; 2021 Aug; 278():119561. PubMed ID: 33915132
[TBL] [Abstract][Full Text] [Related]
53. Nanomedicine as a potential approach to empower the new strategies for the treatment of preeclampsia.
Valero L; Alhareth K; Gil S; Lecarpentier E; Tsatsaris V; Mignet N; Fournier T; Andrieux K
Drug Discov Today; 2018 May; 23(5):1099-1107. PubMed ID: 29391261
[TBL] [Abstract][Full Text] [Related]
54. Dosage Form Developments of Nanosuspension Drug Delivery System for Oral Administration Route.
Chen A; Shi Y; Yan Z; Hao H; Zhang Y; Zhong J; Hou H
Curr Pharm Des; 2015; 21(29):4355-65. PubMed ID: 26323418
[TBL] [Abstract][Full Text] [Related]
55. Smart drug delivery nanocarriers with self-assembled DNA nanostructures.
Li J; Fan C; Pei H; Shi J; Huang Q
Adv Mater; 2013 Aug; 25(32):4386-96. PubMed ID: 23765613
[TBL] [Abstract][Full Text] [Related]
56. Topical drug delivery systems: a patent review.
Singh Malik D; Mital N; Kaur G
Expert Opin Ther Pat; 2016; 26(2):213-28. PubMed ID: 26651499
[TBL] [Abstract][Full Text] [Related]
57. Inhalable nanotherapeutics to improve treatment efficacy for common lung diseases.
Anderson CF; Grimmett ME; Domalewski CJ; Cui H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jan; 12(1):e1586. PubMed ID: 31602823
[TBL] [Abstract][Full Text] [Related]
58. Nanostructured Therapeutic Carriers for Tuberculosis Treatment: Approaches & Challenges.
Ullah Z; Athar MT; Samad A
Recent Pat Antiinfect Drug Discov; 2017; 12(2):128-137. PubMed ID: 28990537
[TBL] [Abstract][Full Text] [Related]
59. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature.
Karabasz A; Bzowska M; Szczepanowicz K
Int J Nanomedicine; 2020; 15():8673-8696. PubMed ID: 33192061
[TBL] [Abstract][Full Text] [Related]
60. The prominence of the dosage form design to treat ocular diseases.
Campos PM; Petrilli R; Lopez RFV
Int J Pharm; 2020 Aug; 586():119577. PubMed ID: 32622806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
